Purple Biotech Ltd (PPBT) Annual Balance Sheets

Annual · GAAP · USD millions
Access PPBT quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Purple Biotech Ltd's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents8.72
Cash & Short-term Investments8.00
Notes Receivable, Current0.01
Other Current Assets0.00
Total Current Assets9.87
Equipment/Property/Plant Net0.12
Intangible Assets7.36
Other Assets, Noncurrent0.00
Shortterm Deposits Not Classified As Cash Equivalents-
Other Current Assets0.38
Intangible Assets Other Than Goodwill27.84
Total Assets17.57
Liabilities
Other Liabilities, Current0.00
Total Current Liabilities7.75
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Trade And Other Current Payables To Trade Suppliers1.46
Other Current Payables1.20
Total Liabilities7.75
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity9.66
Total Stockholder's Equity9.66
Liabilities & Stockholder's Equity17.57
4 historic quarters locked

Sign in to unlock the full Purple Biotech Ltd balance sheet history.

About Purple Biotech Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-031365

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License